Unicamp Blood Centre, Campinas, San Paolo, Brazil.
Blood Transfus. 2021 Sep;19(5):413-419. doi: 10.2450/2020.0073-20. Epub 2020 Oct 9.
Rh antibodies produced by patients receiving Rh-matched RBC units may be associated with inheritance of altered RH alleles or a result of altered Rh epitopes on donor red blood cells (RBC). On this background, our aim was to evaluate unexpected Rh antibodies in Brazilian patients receiving regular transfusions and determine the clinical significance of the alloantibody produced.
We investigated seven patients (5 with sickle cell disease, 1 with myelodysplastic syndrome and 1 with β-thalassaemia) with unexplained Rh antibodies. All patients had complete serological and molecular analyses. A lookback at the donor units transfused to these patients was performed and donors suspected of having Rh variants were recruited for further analysis. Laboratory and clinical findings were used to evaluate the clinical significance of the alloantibodies produced.
The unexpected Rh antibodies found in the patients were not linked to the expression of partial Rh phenotypes according to serological and molecular analyses. Anti-D was found in two patients, anti-C was found in one patient, anti-c was found in one patient and anti-e was found in three patients carrying conventional D, C, c and e antigens respectively. Serological and molecular analyses of donors' samples revealed that six donors whose RBC were transfused to these patients carried partial Rh antigens. Only one anti-e in a patient with β-thalassaemia was autoreactive and could not be explained by RH diversity in his donors. Three of the seven Rh antibodies were associated with laboratory and clinical evidence of a delayed haemolytic transfusion reaction or decreased survival of transfused RBC at first detection.
Our study provides evidence that patients exposed to RBC units from donors with Rh variants may develop antibodies and some of these may be of clinical significance.
接受 Rh 型相合红细胞(RBC)单位输注的患者产生的 Rh 抗体可能与改变的 RH 等位基因遗传有关,或者是由于供者 RBC 上 Rh 表位改变所致。在此背景下,我们的目的是评估在接受常规输血的巴西患者中意外出现的 Rh 抗体,并确定产生的同种异体抗体的临床意义。
我们研究了 7 名(5 名患有镰状细胞病,1 名患有骨髓增生异常综合征,1 名患有β-地中海贫血)原因不明 Rh 抗体的患者。所有患者均进行了完整的血清学和分子分析。对这些患者输注的供者单位进行了回溯,并招募了疑似存在 Rh 变异的供者进行进一步分析。利用实验室和临床发现评估产生的同种异体抗体的临床意义。
根据血清学和分子分析,患者中发现的意外 Rh 抗体与部分 Rh 表型的表达无关。两名患者发现抗-D,一名患者发现抗-C,一名患者发现抗-c,三名分别携带常规 D、C、c 和 e 抗原的患者发现抗-e。对供者样本的血清学和分子分析显示,输注给这些患者的 RBC 的 6 名供者携带部分 Rh 抗原。只有一名β-地中海贫血患者的抗-e 为自身反应性,不能用其供者的 RH 多样性来解释。7 种 Rh 抗体中有 3 种与实验室和临床证据表明迟发性溶血性输血反应或首次检测到输注 RBC 存活率降低有关。
我们的研究提供了证据表明,暴露于 Rh 变异供者 RBC 单位的患者可能会产生抗体,其中一些可能具有临床意义。